Normal heart development is orchestrated by a set of highly conserved transcription factors that includes GATA4, Nkx2-5, and Tbx5. Heterozygous mutation of each of these genes causes congenital heart disease in humans. In mouse models, haploinsufficiency for Nkx2-5 or Tbx5 resulted in an increased incidence of structural heart disease, confirming that normal heart development is sensitive to small changes in expression levels of Nkx2-5 and Tbx5. However, mice haploinsufficient for GATA4 have not been reported to have cardiac abnormalities. We generated two new GATA4 alleles, GATA4
Introduction
Congenital heart disease is the most common major congenital anomaly, with an incidence of 1 in 200 live births (Hoffman, 1995) . Growth and maturation of the fetal heart is regulated by a set of highly conserved transcription factors that includes GATA4, Nkx2-5, and Tbx5 (Srivastava and Olson, 2000) . Mutation of one copy of these genes is associated with cardiac malformations in humans, presumably as a result of haploinsufficiency (Basson et al., 1997; Garg et al., 2003; Pehlivan et al., 1999; Schott et al., 1998) . The sensitivity of heart development to dosage of Nkx2-5 or Tbx5 was recapitulated in mouse models in which targeted ablation of one copy of these genes resulted in an increased frequency of cardiac malformations (Biben et al., 2000; Bruneau et al., 2001) . However, the pathogenesis of heart malformations in humans with missense or nonsense mutations in GATA4 is less well understood since haploinsufficiency for GATA4 in mice was not reported to be associated with cardiac malformations (Kuo et al., 1997; Molkentin et al., 1997) .
The zinc finger transcription factor GATA4 and its binding partner FOG2 are essential components of the fetal cardiac transcriptional program. Null mutation of GATA4 resulted in abnormal ventral folding of the embryo, failure to form a single ventral heart tube, and lethality by embryonic day (E) 10.5 (Kuo et al., 1997; Molkentin et al., 1997) . GATA4 is also essential for later cardiac morphogenesis since embryos homozygous for a GATA4 point mutation (GATA4 Ki ) that abolished interaction with FOG2 died just after E12.5. These embryos had cardiac malformations that included hypoplasia of the compact myocardium, common atrioventricular canal (CAVC), and double outlet right ventricle (DORV) (Crispino et al., 2001) . Similarly, FOG2 null embryos had hypoplasia of the compact myocardium, CAVC, and normally related great arteries (Tevosian et al., 2000) . Strikingly, both GATA4 Ki/Ki and FOG2 null hearts were reported to have an absence of the coronary vasculature (Crispino et al., 2001; Tevosian et al., 2000) .
Using gene targeting, we generated a new hypomorphic allele of GATA4, GATA4
H , which expressed reduced amounts of GATA4 protein. In this report, we characterize mouse embryos homozygous for this hypomorphic allele and demonstrate that the level of cardiac GATA4 expression is an important regulator of cardiomyocyte proliferation, cardiac morphogenesis, and embryo survival.
Materials and methods

Gene targeting
A bacterial artificial chromosome containing GATA4 genomic DNA was isolated from a 129/SvJ BAC library (Genome Systems). A targeting vector was constructed using the following fragments ( Fig. 1a) : (1) a thymidine kinase gene; (2) a 1268-bp NsiI-NheI fragment containing GATA4 genomic DNA including the 5Vend of exon 2; (3) an oligonucleotide containing a loxP site and an XhoI site; (4) a 1302-bp NheI-EcoRV fragment containing GATA4 genomic DNA including the 3V end of exon 2; (5) an FrtKan-Neo-Frt-loxP cassette; and (6) a 2762-bp EcoRVEcoRI fragment containing GATA4 genomic DNA from the second intron. The targeting vector was used to modify the GATA4 locus of embryonic stem cells by homologous recombination. Neomycin-resistant clones were tested for correct gene targeting by Southern blotting using 5V and 3V probes (Fig. 1b) and by PCR using primer pairs spanning the targeting vector and flanking genomic DNA (not shown). To confirm proper activity of loxP and Frt sites, colonies derived from transient transfection of a targeted ES cell clone with a plasmid expressing either Cre or Flp recombinase were tested for loss of Neo resistance. Seven out of 48 colonies were sensitive to G418 after transient Flp expression. Twenty-three out of 48 colonies were sensitive to G418 after transient Cre expression. No colonies were sensitive to G418 after transfection with a control plasmid. Southern blotting of Neo-sensitive colonies confirmed expected DNA recombination (Fig. 1c) .
Mice
Chimeric mice were generated from one properly targeted clone by blastocyst injection. Germline transmission was achieved by mating to C57BL6 mice. Mice used in this study were on a mixed 129/C57BL6 genetic background, backcrossed to C57BL6 2-5 generations. DNA extracted from tail biopsies and yolk sacs were genotyped by PCR (primers and protocols available on request). Susan Dymecki provided hactBDFLPe transgenic mice (Rodriguez et al., 2000) . EIIaCre mice were obtained from Fred Alt (Williams-Simons and Westphal, 1999) . Timed matings were performed by examining females for vaginal plugs, with noon of the day of the plug defined as day 0.5. For BrdU labeling, 2 mg BrdU was administered by intraperitoneal injection 2 h before sacrifice.
Embryo physiology
Preparation and hemodynamic evaluation of mouse embryos were performed as described previously (Ishiwata et al., 2003) . In brief, each embryo was exposed in a bath containing Hank's balanced salt solution at 378C. The ventricular systolic and diastolic areas were obtained by tracing the epicardial border on frontal images recorded with a color CCD camera mounted on a stereoscopic microscope. Blood velocities across ventricular inflow were measured with a 20-MHz pulsed Doppler velocimeter. Blood pressure in ventricles was measured with a servo-null micropressure system attached to a 10-Am glass pipette that was inserted directly into the ventricle.
Histology
Embryos were fixed overnight in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Five-to 10-Am sections were cut and stained with hematoxylin and eosin. Three-dimensional reconstruction was performed using SURFdriver software. BrdU staining was performed on paraffin sections using BrdU antibody (Sigma), the M.O.M. staining kit (Vector), and tyramide-Cy3 (Perkin-Elmer) as the HRP substrate. Nuclei were counterstained with TOPRO3 (Molecular Probes), and cardiomyocytes were stained with a rabbit desmin antibody (BioMeda) and donkey anti-rabbit Alex488 (Molecular Probes). TUNEL staining was performed on paraffin sections using the TMR Red in situ Death Detection Kit (Roche). Fluorescent images were acquired with a confocal microscope (Bio-Rad).
Gene expression
In situ hybridization was performed as described previously (Tanaka et al., 1999) , using 35 S-labeled probes for GATA4 (Molkentin et al., 1997) , ANF (Zeller et al., 1987) , and N-myc (Tanaka et al., 1999) . Quantitative realtime RT-PCR (qRT-PCR) was performed on an ABI7700 using Taqman probes for GATA4, GATA6, MEF2C, Nkx2-5, BMP4, cyclins D1-D3, and HOP and normalized to 18 S rRNA. ANF, BNP, and GAPDH were measured by qRT-PCR using Sybr Green detection. Primer and probe sequences are available at http://www.cardiogenomics.org. Total RNA from E12.5 or E13.5 hearts was isolated using the RNeasy kit (Qiagen) with on-column DNase digestion. Each sample consisted of two to three pooled hearts, assayed in duplicate. Three samples were analyzed per group. Western blots were performed using 50 Ag of total protein. GATA4 was detected with rabbit polyclonal antibody (Santa Cruz) and normalized to GAPDH (Research Diagnostics).
Results
Generation of gene-targeted mice
To circumvent the extracardiac early embryonic lethality seen in GATA4 null embryos, we generated a floxed GATA4 allele (Fig. 1a) . A targeting construct was used to modify the GATA4 locus in embryonic stem cells by homologous recombination, yielding the allele GATA4 H . The targeted allele contains a loxP site in the 5Vuntranslated region of exon 2, 468 bp upstream of the initiation codon, and a neomycin resistance cassette in the second intron. The loxP site was oriented so that no ATG sequence was introduced in the 5V untranslated region. Correct targeting was verified by Southern blotting (Fig. 1b) and PCR (not shown). Properly targeted ES cells were used to generate gene-targeted mice. GATA4
wt/H mice were mated to EIIaCre mice (Williams-Simons and Westphal, 1999) to delete exon 2 in the germline, creating the allele GATA4 D (Fig. 1a ), which is similar in structure to a previously described null allele (Kuo et al., 1997) . To delete the resistance cassette, GATA4
wt/H mice were mated to hactBDFLPe transgenic mice (Rodriguez et al., 2000) , giving the allele GATA4 flox (Fig. 1a) .
Detailed analysis of each of these alleles indicated that GATA4 D is a null allele, while GATA4 H is a severe and GATA4 flox a mild hypomorphic allele. Analysis of embryos from timed matings between GATA4 wt/D mice showed that GATA4 D/D embryos did not survive beyond E10.5 (Fig. 2 ). Mutant embryos displayed severe abnormalities of ventral folding (data not shown), consistent with previously described GATA4 null alleles (Kuo et al., 1997; Molkentin et al., 1997) . Intercrosses between GATA4
wt/H mice did not produce any live GATA4
H/H offspring (0/167), and analysis of litters from timed matings showed that GATA4 H/H embryos died between E13.5-E16.5 (Fig. 2) . These findings demonstrated that GATA4 H is a hypomorphic allele. Removal of the neomycin resistance cassette resulted in GATA4 flox , which is compatible with normal survival since intercrosses between GATA4 wt/flox mice produced GATA4 flox/flox offspring at the expected Mendelian frequency (32/132, 24%; Fig. 2 ). Reduced GATA4 protein expression from GATA4 H To determine the reason that the GATA4 H allele fails to support normal survival, we compared expression of GATA4 mRNA and protein in hearts from E13.5 GATA4
H/H embryos and wild-type littermates. In situ hybridization revealed that GATA4 transcripts were normally distributed in GATA4
H/H hearts (Fig. 3a) . In both wild-type and mutant embryos, GATA4 is expressed at highest levels in the endocardium of the atrioventricular canal and in the atrioventricular endocardial cushions (Figs. 3a and b). Robust GATA4 expression was also present in wild-type and mutant myocardium (Figs. 3a and b) . In E10.5 embryos, GATA4 was expressed similarly in the proepicardial derivatives of both wild-type and mutant hearts (data not shown). By E14, the epicardium is relatively thin and expression in this structure is difficult to resolve from myocardial expression by radioactive in situ hybridization. In the atrioventricular grooves, where epicardial cells tend to be heaped up, epicardial GATA4 expression was detected in both wild-type and mutant embryos (Fig. 3b) . By Northern blotting, GATA4 transcripts from mutant hearts were normal in size and 30% reduced in abundance (Fig. 3c, left panel) . qRT-PCR showed that GATA4 mRNA levels were normal in GATA4 flox/flox hearts but 50% reduced in GATA4 H/H hearts (Fig. 3c, right panel) . Sequencing of GATA4 cDNA fragments amplified from GATA4
H/H hearts demonstrated that the coding region was identical to wild type, and no aberrant splice variants could be detected by PCR using primers spanning each intron-exon junction.
By Western blotting, GATA4 protein expressed from the GATA4 H allele was normal in size (Fig. 3d) . The amount of GATA4 protein, normalized to GAPDH, was reduced by 70% in GATA4
H/H hearts (Fig. 3d) . In GATA4 flox/flox hearts, GATA4 protein was present at an intermediate level (50% reduction compared to wild-type controls; Fig. 2c ). This small difference in GATA4 protein levels was associated with a profound difference in embryonic survival (Fig. 2) .
Abnormal cardiac morphogenesis in GATA4
H/H embryos By E13.5, GATA4 H/H embryos appeared edematous and the right atrium was dilated, displacing the heart to the left (Figs. 4a and b) . Mutant hearts had common atrioventricular canal (CAVC), usually well balanced but occasionally with a relatively small right ventricle ( Fig. 4b ; Table 1 ). The interventricular septum had a characteristic spongiform appearance ( Fig. 4b; Table 1 ), and the compact and trabecular myocardium were markedly hypoplastic (Figs. 4b and 5a and b). The aorta was connected with the right ventricle, resulting in a double outlet right ventricle (Figs. 4b and c) . A subaortic H/H and wild-type hearts, detected by in situ hybridization using a full-length GATA4 probe. White box indicates area magnified in panel b. (b) Higher magnification of the right atrioventricular groove. To facilitate anatomical localization of the GATA4 in situ hybridization signal, it is displayed as blue pseudocolor overlaid on the bright-field eosin-stained image. GATA4 is expressed in endocardium (En), myocardium (Myo), and epicardium (Ep). RA, right atrium; RV, right ventricle. (c) GATA4 mRNA from E13.5 GATA4
H/H and GATA4 +/+ hearts. GATA4 transcript was analyzed by Northern blotting using a full-length GATA4 probe, and by quantitative RT-PCR, normalized to 18 S rRNA. *P b 0. conus was present (not shown), and the aortic valve was inferior, posterior, and to the right of the pulmonary valve (Fig. 4c) .
A previously described GATA4 hypomorphic allele, GATA4
Ki , expressed normal amounts of a mutant GATA4 protein that failed to interact with FOG2 due to a V217G mutation. GATA4
Ki/Ki embryos died around E12.5, and like GATA4
H/H hearts, GATA4 Ki/Ki hearts had CAVC, DORV, and ventricular hypoplasia. GATA4 Ki/Ki hearts had a striking paucity of coronary vasculature (Crispino et al., 2001 ). In contrast, we found that GATA4 H/H hearts had normal, bloodfilled epicardial coronary vessels (Figs. 4d-f) . PECAM staining demonstrated the presence of intramyocardial coronary vessels (Fig. 4g) .
Hypoplasia of the compact and trabecular myocardium in GATA4
H/H embryos (Figs. 5a and b) may have been due to increased cardiomyocyte apoptosis or decreased cardiomyocyte proliferation. TUNEL staining of E12.5 and E13.5 hearts did not reveal a difference in the rate of apoptosis between mutant embryos and wild-type littermate controls (data not shown). However, cardiomyocyte proliferation, as assessed by BrdU labeling, was significantly decreased in GATA4 H/H compact myocardium compared to wild-type littermate controls at E12.5 (Figs. 5c and d) . While mutant hearts also had marked hypoplasia of the trabecular myocardium, we did not detect a difference in the frequency of BrdU-positive cells in the trabecular myocardium at E12.5 (Fig. 5d) .
Trabecular myocardium and compact myocardium have distinct gene expression programs. In normal hearts, at E13.5 ANF was expressed at high levels in trabecular but not compact myocardium (Fig. 5e ), while N-myc was expressed at higher levels in compact compared to trabecular myocardium (Fig. 5f ). The outer margin of ANF expression and the inner margin of N-myc expression (dashed line, Figs. 5e-f) coincided with the morphological junction between compact and trabecular myocardium (solid 
line, Figs. 5e-f). In GATA4
H/H embryos, ANF continued to be expressed at high levels in trabecular myocardium, but the outer margin of ANF expression (dashed line) occurred in a region of myocardium with a trabecular appearance (Fig. 5e) . Similarly, the inner margin of N-myc expression (dashed line) occurred in a region of myocardium with a trabecular appearance (Fig. 5f ). These data indicate that in mutant embryos there was a region of dysplastic myocardium that expressed the genetic program of compact myocardium but had trabecular morphology.
Impaired diastolic function Of GATA4 H/H hearts
To determine the effect of the hypomorphic GATA4 mutation on embryo cardiac function, we used video imaging, Doppler velocimetry, and intracardiac pressure measurements to evaluate the hemodynamics of E13.5 embryos ( Fig. 6; Table 2 ). We found that ventricular size was no different between mutant and wild-type embryos (Table 2 ). Systolic function, as assessed by area ejection fraction and +dP/dt, was also normal in GATA4 H/H embryos, although peak ventricular pressure was reduced in mutant embryos (Table 2) , perhaps as a result of atrioventricular regurgitation (see below). Diastolic function, as assessed by the ratio of early (bEQ) to late (bAQ) ventricular inflow velocities, ÀdP/dt, ventricular end-diastolic pressure, and ventricular sucking pressure, was severely impaired in GATA4
H/H embryos (Table 2) . We also qualitatively assessed competency of the atrioventricular (AV) valves by measuring blood flow in the inferior vena cava. We detected systolic retrograde flow in mutant embryos, indicating that the hypoplastic AV valves of mutant hearts were regurgitant (Fig. 6c ).
Gene expression in GATA4 H/H hearts
To determine if chamber-and subregion-specific genetic programs were normally specified in GATA4
H/H embryos, we used in situ hybridization to detect subregion-restricted transcripts. MLC2a and MLC2v, which are restricted to atrial and ventricular myocardium, respectively, were normally expressed in GATA4
H/H hearts (data not shown). Tbx5 retained its normal preferential expression in the atria and the left ventricle (data not shown).
Based on promoter assays in transfected cultured cells and in some cases promoter studies in transgenic animals, GATA4 has been implicated in the regulation of a number of genes expressed in the heart. To determine if variation of GATA4 expression levels within a physiologically relevant range influences expression of putative GATA4 target genes, we measured the expression of selected genes by quantitative RT-PCR (Fig. 7) . GATA6 expression was not altered in GATA4
H/H embryos, in contrast to the compensatory upregulation of GATA6 reported in GATA4 null embryos (Molkentin et al., 1997) . Although in vivo promoter analysis indicated that GATA sites were essential for normal activity of the Nkx2-5 and MEF2C enhancers (Lien et al., 1999; Searcy et al., 1998; B. Black, personal communication) , Nkx2-5 levels were up-regulated twofold in GATA4 H/H hearts while MEF2C expression was unchanged (Fig. 7) . Likewise, ANF and BNP expression levels were not altered in GATA4
H/H hearts (Fig. 7) despite the extensive literature suggesting an important role for GATA4 in the activation of these promoters. Because of the reduced replication rate of GATA4
H/H myocytes, we also measured expression of cyclin D1-3 and the homeodomain only protein (HOP), which regulates myocardial growth and is a direct target of the GATA4 interacting transcription factor Nkx2-5 (Chen et al., 2002; Shin et al., 2002) . Cyclin D2, cyclin D3, and HOP expression were not significantly changed in E12.5 mutant hearts, while cyclin D1 expression was slightly up-regulated in mutant hearts (Fig. 7) . Finally, we examined the expression of BMP4 because BMP4 has been reported to be a target of GATA4 and atrioventricular canal formation is sensitive to BMP4 dosage. We did not detect a difference in BMP4 expression by in situ hybridization in E10.5 hearts (data not shown) or by RT-PCR in E13.5 hearts (Fig. 7) .
Discussion
GATA4 regulation of cardiac morophogenesis
We have generated and characterized a hypomorphic allele of GATA4, GATA4 H . GATA4 H/H embryos expressed 70% lower levels of GATA4 protein (Fig. 3) . These mutant hearts had CAVC, DORV, and myocardial hypoplasia (Fig.  4) . GATA4
H/H embryos died between E13.5 and E16.5, with right atrial dilatation and peripheral edema suggestive of congestive heart failure. In comparison, GATA4 flox/flox embryos, which had a 50% reduction of GATA4 protein (Fig. 3) , survived normally ( Fig. 2) and had normal postnatal cardiac function and fertility (WTP and SI, unpublished data). These data indicate that small changes in the level of GATA4 protein expression can dramatically influence cardiac morphogenesis and embryonic survival. Consistent with this conclusion is the association of mutations of GATA4 with cardiac septation defects in humans (Garg et al., 2003) . The extent to which the GATA4 H allele reduced GATA4 expression is within the range of GATA4 down-regulation that has been seen with experimental retinoic acid deficiency (Kostetskii et al., 1999) and with perturbation of embryonic calcium homeostasis (Porter et al., 2003) , suggesting that altered GATA4 activity may contribute to congenital heart disease due to both genetic and environmental factors.
The morphology of GATA4 Ki/Ki hearts was similar to GATA4 H/H hearts, with both having CAVC, DORV, and marked hypoplasia of the compact myocardium (Crispino et al., 2001 ). This similarity indicates that many dosagesensitive aspects of GATA4 function in late cardiac morphogenesis are dependent upon interaction with a FOG cofactor. Both GATA4 Ki/Ki and GATA4 H/H hearts have striking myocardial hypoplasia (Fig. 5) . The hypoplasia of the compact myocardium in GATA4 H/H embryos was due at least in part to decreased cardiomyocyte replication at E12.5. Although we did not find a difference in BrdU labeling index in trabecular myocardium at E12.5 or E13.5, it is possible that earlier time points would have to be examined since the most rapid rate of growth of trabecular myocardium precedes E12.5 (Ishiwata et al., 2003) . GATA factors have been implicated in the regulation of cell proliferation in other systems, potentially through the regulation of cyclin D2 (Kitta et al., 2003; Suzuki et al., 2003; Tanaka et al., 2000; Wang et al., 1996) . However, we found that transcription of cyclins D1-3 was unaltered or 
001). (c) BrdU staining (red) of GATA4
H/H and wild-type left ventricle at E12.5. Nuclei were detected by TOPRO-3 staining (blue). Lower panels are the same images as the upper panels, with cardiomyocytes identified by desmin staining (green). Arrows indicate BrdU-positive cardiomyocyte nuclei. (d) Quantitative analysis of cell replication in E12.5 mutant and wild-type hearts. BrdU labeling index was calculated as the ratio of BrdU-positive cardiomyocyte nuclei to total cardiomyocyte nuclei. More than 200 nuclei were counted for each measurement per embryo. Mutant embryos were compared to their respective wild-type littermates. Each group contained three embryos. *P b 0.05. NS, no significant difference. (e) Abnormal regional expression of ANF in mutant hearts. In control hearts, ANF (blue in situ hybridization signal) was expressed in trabecular myocardium all the way to the junction with compact myocardium (solid line). In mutant hearts, the ANF expression domain (dashed line) did not extend to the morphological compact myocardium. The bracket indicates a region with trabecular appearance but lacking ANF expression. (f) Abnormal regional expression of N-myc in mutant hearts. In control hearts, N-myc was most highly expressed in compact myocardium (blue in situ hybridization signal). In mutant hearts, the domain of higher level N-myc expression (dashed line) extended beyond the morphological compact myocardium (solid line).
slightly up-regulated in GATA4
H/H embryos (Fig. 7) . Likewise, transcription of HOP, a regulator of myocardial growth and a target gene of the GATA4 interacting transcription factor Nkx2-5 (Chen et al., 2002; Shin et al., 2002) , was not changed in GATA4
H/H embryos (Fig. 7) . While the overall phenotype of GATA4 Ki/Ki and GATA4 H/H hearts was similar, unlike GATA4 Ki/Ki hearts GATA4 H/H hearts had blood filled epicardial and intramyocardial coronary vessels (Figs. 4d-g ). This difference suggests that coronary vessel formation requires GATA4-FOG interaction but is not sensitive to a moderate reduction in GATA4 levels. This implies that GATA4 is necessary for coronary vessel formation but might not be a dose-limiting regulator of this process. Although our analysis cannot completely exclude abnormal perfusion due to abnormal coronary vessel density or microvascular function, the equivalent severity of myocardial hypoplasia despite a marked difference in coronary vascularity in the GATA4 Ki/
Ki versus GATA4
H/H mutant hearts suggests that the myocardial hypoplasia is not secondary to abnormal perfusion.
We found that the expression domains of ANF and Nmyc, markers that delineate the boundary between compact and trabecular myocardium, were perturbed in mutant embryos (Figs. 4e-f) so that mutant embryos had a zone with the morphology of trabecular myocardium but the genetic program of compact myocardium (reduced ANF expression, increased N-myc expression). This phenotype is reminiscent of ventricular noncompaction, a frequent finding in childhood cardiomyopathy (Nugent et al., 2003) and a finding associated with a chromosomal microdeletion that includes GATA4 (Pehlivan et al., 1999) . The thin myocardial phenotype of GATA4 H/H hearts suggests that GATA4 and its transcriptional targets are candidate genes for human cardiomyopathies.
GATA4 expression in ventral endoderm has previously been demonstrated to be sufficient to rescue the defect of ventral morphogenesis seen in GATA4 null embryos (Narita et al., 1997) . GATA4
H/H embryos undergo normal ventral morphogenesis, suggesting that either the requirement for GATA4 is less sensitive to expression level in the ventral endoderm compared to the heart or that the GATA4 H allele 
Fig. 7. Gene expression in GATA4
H/H hearts. Relative expression of GATA4 target genes, normalized to GAPDH (ANF, BNP) or 18 S, in wildtype and H/H hearts. Expression was measured by qRT-PCR using total RNA from E13.5 hearts. *P b 0.05. NS, no significant difference. Three samples, each composed of hearts from two embryos, were used for each group and each measurement was made in duplicate. expresses higher amounts of GATA4 in the ventral endoderm than in the heart.
Hemodynamic abnormalities leading embryonic lethality
Like FOG2
D/D embryos (Ishiwata et al., 2003) , GATA4
H/H embryos had severely diminished ventricular diastolic function and normal systolic function (Fig. 6) . While it might seem counterintuitive that the thinner mutant ventricle was stiffer than wild-type ventricle, diastolic ventricular filling is an active process. The compact myocardium expresses relatively higher levels the calcium handling proteins SERCA2A, phospholambam, and sodium-calcium exchanger (NCX1) than the trabecular myocardium, and early ventricular filling is exponentially related to the area of the compact myocardium (Ishiwata et al., 2003) . Our finding that the thinner walled mutant myocardium had impaired diastolic function is consistent with these data. In addition to their effects on myoarchitecture, GATA4 and FOG2 may also influence diastolic function by altering the expression of cardiac genes that are important for ventricular relaxation. Our hemodynamic measurements describe the pathophysiology leading to death in GATA4 H/H embryos. During systole, a fraction of the ventricular output regurgitated retrograde due to incompetence of the hypoplastic atrioventricular valves. In the setting of AV regurgitation, normal rather than supranormal area ejection fraction suggests the possibility that the mutant embryos also had latent systolic dysfunction. During diastole, the regurgitant volume did not reenter the ventricle (EDA was normal rather than increased in mutant embryos) because of impaired ventricular relaxation. As a result, diastolic pressures were elevated, leading to atrial enlargement and peripheral edema in mutant embryos (Fig. 4) . Moreover, forward cardiac output was reduced, resulting in death of the embryo. We suspect that impaired ventricular filling is an important component of the hemodynamic derangements present in other embryos with hypoplasia of the compact myocardium.
Regulation of GATA4 downstream targets
GATA4 has been implicated in the regulation of a large number of cardiac genes (reviewed by Molkentin, 2000) , based largely on reporter assays in cell culture or in transgenic animals. We tested the hypothesis that GATA4 is a dosage-limiting regulator of transcription of a number of putative target genes. While ANF, BNP, cyclin D2, and BMP4 promoters are GATA4 responsive in transient transfection assays, we found that decreased GATA4 protein levels did not alter expression of these genes in vivo (Figs. 5e and 7), suggesting that changes in GATA4 level within a physiological range do not alter the expression of these genes in late cardiogenesis. Consistent with this finding, ANF was normally expressed in GATA4 null hearts (Molkentin et al., 1997) . However, we cannot exclude more complex models in which down-regulation resulting from decreased GATA4 protein levels is masked by up-regulation due to other factors, such as heart failure.
The enhancers of the transcription factors Nkx2-5 and MEF2C contain GATA4 binding sites, and mutation of these sites altered expression of these genes in transgenic reporter mice (Lien et al., 1999; Searcy et al., 1998; B. Black, personal communication) . However, MEF2C and Nkx2.5 transcript levels were unaffected or twofold upregulated, respectively, in GATA4
H/H hearts, indicating that the expression of these genes is not sensitive to a moderate reduction of GATA4 activity late in cardiogenesis. This does not exclude an important role of GATA4 in inducing or maintaining the expression of these genes at other stages of development. The up-regulation of Nkx2-5 in GATA4
H/H hearts was unexpected and may be secondary to the increased wall stress in mutant hearts. Nkx2-5 was upregulated by increased wall stress in adult hearts (Thompson et al., 1998) .
Conclusion
GATA4 is an essential, dosage-dependent regulator of cardiac morphogenesis. A threshold level of GATA4 between 30% and 50% of normal is required for normal heart development and embryonic survival. Reduction of GATA4 protein below this threshold resulted in reduced cardiomyocyte replication, myocardial hypoplasia, and endocardial cushion defects.
